Transgenic mice overexpressing Atrogin-1 in the heart demonstrated a blunted cardiac hypertrophy in a pathophysiological model of transverse aortic constriction (TAC) by reduction of calcineurin levels (Li et al., 2004). The gene discussed is FBXO32; the disease is cardiac hypertrophy.